The global Coronary Stents Market is projected to reach a substantial USD 51.2 billion by 2032, reflecting a steady growth ...

As the field of interventional cardiology continues to evolve, innovations in imaging and stent-free treatment methods are ...

A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...

In the PROGRESS-AMS trial, Erbel and colleagues assessed the feasibility of bioabsorbable coronary stents made from a magnesium alloy—demonstrated in animal pilot studies to be completely ...

The estimated Industrial Analysis of Coronary Stent in India in 2023 is USD 843.8 million. The need for less invasive methods ...

Stents are, of course, used in other scenarios to open large arteries ... the majority of patients in the study also showed a ...

Summary: The use of balloon angioplasty with or without coronary artery stenting is limited by the phenomenon of in-stent restenosis (ISR). Until very recently, most efforts to overcome ISR had ...

For percutaneous coronary intervention (PCI) on de novo lesions, the DynamX bioadaptor not only matched drug-eluting stents ...

Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with conventional balloon angioplasty prior ...